Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional
Official Title: Sulodexide Treatment in Patients With Dense Deposit Disease
Brief Summary:
The purpose of this study is to see if a medicine called Sulodexide will help prevent or slow down the progression of Membranoproliferative Glomerulonephritis type II/Dense Deposit Disease. Sulodexide is not yet FDA approved and has not been studied in children.
Study aim/hypotheses: to measure the efficacy of Sulodexide treatment in patients with the above disease/s.